Goa to Start Administering Remdesivir to Coronavirus Patients

Remdesivir, an anti-viral drug, is administered to COVID-19 patients by Goa's Health Ministry for faster recovery.

Goa's Health Ministry started administering Remdesivir, an anti-viral drug which is administered to COVID-19 patients for faster recovery.

"This anti-viral drug will be beneficial in suppressing the viral replication of SARS-CoV-2, the coronavirus that causes COVID-19. Uncontrollable viral replication is often responsible for tissue damage and deaths in patients infected with the virus," Rane said in a statement.

Coronavirus
Coronaviruses infect animals, humans, and birds. Human coronaviruses, such as SARS, MERS, and 2019-nCoV cause respiratory distress and even death. The S protein is the infectious agent of the virus.

TOP INSIGHT

Introduction of Remdesivir in the coronavirus treatment protocol can help decrease COVID-19 deaths.

The minister also said that the anti-viral drug would be administered to moderately and severely-ill patients suffering from COVID-19 and would help to suppress the viral replication of SARS-CoV-2.

"The drug will help in faster recovery of COVID-19 patients. Introduction of Remdesivir in the COVID-19 treatment protocol will also help us reduce COVID-19 deaths associated with co-morbidity," Rane said.

Goa is currently witnessing a sustained spike in the number of Covid-19 cases. The state has recorded 7,614 coronavirus cases in all, out of which 2,095 are active. 66 people have died after contracting the deadly infection.

Clinical Trials of Therapeutics for COVID-19: Current Status
Clinical trials that are well-designed, well-planned and conducted in a timely manner will ensure the development of a safe and effective drug for the treatment of COVID-19 sooner than later.

Source-IANS

Coronavirus Treatment: Can Antimalarial Drug Prevent COVID-19 Infection
The FDA supports the use of antimalarial drug hydroxychloroquine in clinical trials investigating its effectiveness against COVID-19.

Coronavirus Treatment and Risk to Breastfeeding Women: Study
With the ongoing concern about the coronavirus (COVID-19), which originated in Wuhan, China, and spreading globally, that causes severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), thoughts turn to treatment in general and of nursing mothers, in particular.